Abstract

Inadequate maintenance of systemic blood flow in neonates following preterm birth is associated with increased morbidity and mortality, and may be due in part to structural immaturity of the myocardium. Maternal glucocorticoid administration is associated with improved cardiovascular function, and possibly promotes structural maturation of the myocardium. This study assessed the structural maturity of the myocardium in male and female preterm and term piglets, and preterm piglets exposed to a regimen of maternal glucocorticoids as used clinically. In preterm, term and glucocorticoid exposed preterm piglets cardiomyocyte maturity was examined by measuring the proportion of binucleated myocytes and the volumes of single living ventricular cardiomyocytes with fluorescence microscopy. Ventricular apoptosis and proliferation were measured by immunohistochemistry. Preterm piglet hearts had fewer binucleated myocytes, smaller myocytes, and more proliferative and fewer apoptotic nuclei than term hearts. Maternal glucocorticoid treatment resulted in increased binucleation with no increase in myocyte volume, and levels of proliferation and apoptosis that were more similar to the term heart. Atrial weights were increased and in female piglets there was an increase in the ratio of left to right ventricular weight. The observed changes in atrial mass and myocyte structural maturation correlated with changes in cardiac function of isolated hearts of littermates. In conclusion, the association between increased myocardial maturation following glucocorticoid exposure, improved cardiac function in littermates, and clinical improvement in human neonatal cardiac function exposed to antenatal glucocorticoids, suggests that glucocorticoid exposure contributes to improved cardiovascular function in preterm infants by promoting myocardial structural maturity.

Highlights

  • The preterm neonate often fails to maintain systemic blood flow and tissue perfusion, and this is associated with increased risk of poor outcomes [1,2,3]

  • Glucocorticoid exposure before birth reduces the incidence of low systemic flow in human infants [6] and the need for blood pressure support [7], and is associated with increased aortic flow in the preterm piglet heart [8]

  • If we can identify the aspects of preterm heart growth and myocyte structure that are improved by antenatal glucocorticoid exposure, this may help to identify the factors that contribute to poor preterm function

Read more

Summary

Introduction

The preterm neonate often fails to maintain systemic blood flow and tissue perfusion, and this is associated with increased risk of poor outcomes [1,2,3]. Glucocorticoid exposure before birth reduces the incidence of low systemic flow in human infants [6] and the need for blood pressure support [7], and is associated with increased aortic flow in the preterm piglet heart [8]. These changes probably contribute to the improved outcome of infants exposed to glucocorticoid antenatally. If we can identify the aspects of preterm heart growth and myocyte structure that are improved by antenatal glucocorticoid exposure, this may help to identify the factors that contribute to poor preterm function

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call